NJ jury awards $25M to Ala. man in Accutane suitAssociated Press
Feb. 23, 2010
Trump On EU: 'People Want Their Own Identity,' Don't Want Migrants 'Coming In & Destroying' Them
While U.S. Media Celebrates Feminization of Boys, China Moves to Prevent 'Masculinity Crisis'
Sweden: Migrant Baby Boom Packs Hospitals; Somali's Birthrate 3.9, Native Swede's 1.8
Justin Trudeau: "I'm a Proud Feminist," Muslims "Essential" to Canada's Success
LOL: 'Never Trump' Signatories 'Fear They've Been Blacklisted'
ATLANTIC CITY, N.J. -- A New Jersey jury has hit the pharmaceutical company that makes Accutane with a $25.16 million judgment in a lawsuit filed by an Alabama man who blamed the drug for his inflammatory bowel disorder.
Thirty-eight-year-old Andrew McCarrell of Moody, Ala., took the acne drug in his 20s. He says Hoffmann-La Roche Inc. failed to adequately warn of its side effects. McCarrell eventually had his colon removed.
The compensatory damages award came Tuesday in a retrial. An appeals court overturned a $2.6 million judgment he won in May 2007.